Stay updated on Daratumumab in AL Amyloidosis Clinical Trial
Sign up to get notified when there's something new on the Daratumumab in AL Amyloidosis Clinical Trial page.

Latest updates to the Daratumumab in AL Amyloidosis Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedAdded Amyloidosis as a topic and the Genetic and Rare Diseases Information Center resource. Updated the page revision from v3.4.1 to v3.4.2.SummaryDifference0.1%

- Check19 days agoChange DetectedRevision tag updated from v3.4.0 to v3.4.1.SummaryDifference0.0%

- Check34 days agoChange DetectedThe page now shows the exact Last Update Posted date in Study Record Dates, replacing the previous (Estimated) label. This is a minor UI/metadata update and does not modify the study content or how users interact with the page.SummaryDifference0.0%

- Check41 days agoChange DetectedRevision: v3.3.4 replaces v3.3.3; no impact on study details or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedLocations now lists numerous site locations across US states and Canadian provinces. Revision updated to v3.3.3.SummaryDifference1%

- Check84 days agoChange DetectedAdded detailed quality-of-life assessment details for EORTC QLQ-C30 and SF-36, including baseline and multiple follow-up timepoints. The update also enumerates the items and scoring methods used in these QoL instruments.SummaryDifference1%

Stay in the know with updates to Daratumumab in AL Amyloidosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab in AL Amyloidosis Clinical Trial page.